Back
LeMaitre Vascular Vs. Perspective Therapeutics Industry Stock Comparison
Buy
70
LMAT
LeMaitre Vascular
Last Price:
90.04
Seasonality Move:
-0.84%
Sell
31
CATX
Perspective Therapeutics
Last Price:
13.55
Seasonality Move:
-10.19%
Buy
70
LeMaitre Vascular (LMAT)
is a Buy
Is LeMaitre Vascular a Buy, Sell or Hold?
- The current LeMaitre Vascular [LMAT] share price is $90.18. The Score for LMAT is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- LMAT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $13.47. The Score for CATX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LMAT Stock Price Chart
What is LeMaitre Vascular's stock price today?
-
The LeMaitre Vascular share price today is $90.18
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LMAT is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $13.47
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
LMAT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.92 | Buy |
Relative Strength Index (14 RSI): | 59.15 | Buy |
Chaikin Money Flow: | 37288 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (85.99 - 89.95) | Buy |
Bollinger Bands (100): | (76.99 - 87.97) | Buy |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 42.96 | Sell |
Chaikin Money Flow: | -538312 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.95 - 15.75) | Sell |
Bollinger Bands (100): | (11.53 - 15.95) | Sell |
LMAT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 88.56 | Buy |
20-day SMA: | 88.66 | Buy |
50-day SMA: | 86.65 | Buy |
200-day SMA: | 71.78 | Buy |
8-day EMA: | 88.94 | Buy |
20-day EMA: | 88.1 | Buy |
50-day EMA: | 86.02 | Buy |
200-day EMA: | 74.79 | Buy |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.46 | Sell |
20-day SMA: | 14.98 | Sell |
50-day SMA: | 13.73 | Sell |
200-day SMA: | 11.27 | Buy |
8-day EMA: | 14.11 | Sell |
20-day EMA: | 14.44 | Sell |
50-day EMA: | 13.95 | Sell |
200-day EMA: | 11.5 | Buy |
LeMaitre Vascular Earnings Growth & LMAT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.06 per share, an increase this year of $0.51 per share, and an increase next year of $0.20 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.
LeMaitre Vascular Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |